Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Systemic immune-inflammation index (SII), based on peripheral lymphocyte, neutrophil, and platelet counts, was recently investigated as a prognostic marker in several tumors. However, SII has not been reported in esophageal squamous cell carcinoma (ESCC). We evaluated the prognostic value of the SII in 916 patients with ESCC who underwent radical surgery. Univariate and multivariate analyses were calculated by the Cox proportional hazards regression model. The time-dependent receiver operating characteristics (ROC) curve was used to compare the discrimination ability for OS. PSM (propensity score matching) was carried out to imbalance the baseline characteristics. Our results showed that SII, PLR, NLR and MLR were all associated with OS in ESCC patients in the Kaplan-Meier survival analysis. However, only SII was an independent risk factor for OS (HR = 1.24, 95% CI 1.01–1.53, P = 0.042) among these systemic inflammation scores. The AUC for SII was bigger than PLR, NLR and MLR. In the PSM analysis, SII still remained an independent predictor for OS (HR = 1.30, CI 1.05–1.60, P = 0.018). SII is a novel, simple and inexpensive prognostic predictor for patients with ESCC undergoing radical esophagectomy. The prognostic value of SII is superior to PLR, NLR and MLR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Camp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
Pennathur, A., Gibson, M. K., Jobe, B. A., & Luketich, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60643-6 · Cited by 2,390
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Cited by
Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
Yang, R., Chang, Q., Meng, X., Gao, N., & Wang, W. (2018) · Journal of Cancer · doi:10.7150/jca.25691 · Cited by 441
“Geng[8] 2016 China Asian ESCC 916 and 759 307 OS 8 M”
Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer
Huang, H., Liu, Q., Zhu, L., Zhang, Y., Lu, X., Wu, Y., & Liu, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39150-0 · Cited by 408
Guo, W., Song, Y., Sun, Y., Du, H., Cai, Y., You, Q., Fu, H., & Shao, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1071465 · Cited by 335
Zhong, J.-H., Huang, D.-H., & Chen, Z.-Y. (2017) · Oncotarget · doi:10.18632/oncotarget.18856 · Cited by 307
Mahemuti, N., Jing, X., Zhang, N., Liu, C., Li, C., Cui, Z., Liu, Y., & Chen, J. (2023) · Nutrients · doi:10.3390/nu15051177 · Cited by 260
“Cervical cancer [13], esophageal cancer [14], and hepatocellular carcinoma [15] are examples.”
BackgroundLiu, T.-T., Li, R., Huo, C., Li, J.-P., Yao, J., Ji, X.-L., & Qu, Y.-Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.682002 · Cited by 247
Association between Systemic Immune-Inflammation Index and Diabetic Depression
Wang, J., Zhou, D., Dai, Z., & Li, X. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s285000 · Cited by 238
Chao, B., Ju, X., Zhang, L., Xu, X., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00766 · Cited by 203
“(5) Neutrophils release angiogenic factors, such as vascular endothelial growth factor,”
BackgroundQin, Z., Li, H., Wang, L., Geng, J., Yang, Q., Su, B., & Liao, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.863640 · Cited by 189
Geng, Y., Zhu, D., Wu, C., Wu, J., Wang, Q., Li, R., Jiang, J., & Wu, C. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.002 · Cited by 180
Self-citationJomrich, G., Paireder, M., Kristo, I., Baierl, A., Ilhan-Mutlu, A., Preusser, M., Asari, R., & Schoppmann, S. F. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000003370 · Cited by 176
Jomrich, G., Gruber, E. S., Winkler, D., Hollenstein, M., Gnant, M., Sahora, K., & Schindl, M. (2020) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04187-z · Cited by 166
Zhang, H., Shang, X., Ren, P., Gong, L., Ahmed, A., Ma, Z., Ma, R., Wu, X., Xiao, X., Jiang, H., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27052 · Cited by 175
“Our results were consistent with those of previously published reports (Geng et al., 2016; Hirahara et al., 2018).”
ResultErdoğan, M., Erdöl, M. A., Öztürk, S., & Durmaz, T. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0274 · Cited by 128
Wang, Y., Wang, Q., Yang, T. W., Yin, J. M., Wei, F., Liu, H., Yang, P. X., Li, J., Liu, N., Zhu, Y., et al. (2023) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2022.0172 · Cited by 131
“…to predict the prognosis of LT. Results showed that in our LT patients, the SII was a better predictor of patient prognosis than other inflammatory markers, probably because the SII reflected the balance between inflammation and immune response more objectively (Geng et al, 2016; Hu et al, 2014).”
Clinical significance of prognostic nutritional index (PNI) in malignant melanoma
Mirili, C., Yılmaz, A., Demirkan, S., Bilici, M., & Tekin, S. B. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01461-7 · Cited by 121
Wang, Y., Li, Y., Chen, P., Xu, W., Wu, Y., & Che, G. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.08.116 · Cited by 117
Meng, X., Chang, Q., Liu, Y., Chen, L., Wei, G., Yang, J., Zheng, P., He, F., Wang, W., & Ming, L. (2017) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22228 · Cited by 115
Sun, Y., & Zhang, L. (2018) · Cancer Management and Research · doi:10.2147/cmar.s171035 · Cited by 112
“The following clinicopathological parameters extracted from studies were collected for analysis: sex, 34,37 tumor location, differentiation, depth of invasion (T), tumor length,(15,26,33) lymph node metastasis, and TNM stage.(15,20,22,23,26,27,31,32,34,37) We found high NLR was”
BackgroundMethodZhang, W., Wang, R., Ma, W., Wu, Y., Maskey, N., Guo, Y., Liu, J. T., Mao, S., Zhang, J., Yao, X., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.02 · Cited by 97
Zhang, Y., Lin, S., Yang, X., Wang, R., & Luo, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27373 · Cited by 89
“SII is the combination of NLR and platelet count, and it was suggested that SII might perform better than NLR as a prognostic indicator (Aziz et al., 2018; Y. Geng et al., 2016).”
BackgroundGao, Y., Guo, W., Cai, S., Zhang, F., Shao, F., Zhang, G., Liu, T., Tan, F., Li, N., Xue, Q., et al. (2019) · Journal of Cancer · doi:10.7150/jca.30281 · Cited by 90
“The cutoff values for SII were different among these similar studies [21, 22, 40, 41].”
ResultCellular immune response to acute exercise: Comparison of endurance and resistance exercise
Schlagheck, M. L., Walzik, D., Joisten, N., Koliamitra, C., Hardt, L., Metcalfe, A. J., Wahl, P., Bloch, W., Schenk, A., & Zimmer, P. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13412 · Cited by 90
Shi, H., Jiang, Y., Cao, H., Zhu, H., Chen, B., & Ji, W. (2018) · Disease Markers · doi:10.1155/2018/1787424 · Cited by 82
Gao, Y., Zhang, H., Li, Y., Wang, D., Ma, Y., & Qing, C. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.05.059 · Cited by 83
Ruiz‐Ranz, M., Lequerica–Fernández, P., Rodríguez‐Santamarta, T., Suárez-Sánchez, F. J., López‐Pintor, R. M., Garcia-Pedrero, J. M., & de Vicente, J. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.941351 · Cited by 81
Zhang, Y., Xiao, G., & Wang, R. (2019) · Cancer Management and Research · doi:10.2147/cmar.s190006 · Cited by 67
“In addition, SII has shown to be superior to PLR, NLR, and MLR as a predictive biomarker in ESCC.(14,16) And CAR, based on serum C-reactive protein and albumin, was also revealed the great usefulness as a predictor of survival in various types of tumors, including upper GI cancers.”
BackgroundMethodLi, Y., Chang, J., He, M., Wang, H., Luo, D., Li, F., Li, J., & Ran, L. (2021) · Journal of Oncology · doi:10.1155/2021/2939162 · Cited by 73
Ishibashi, Y., Tsujimoto, H., Yaguchi, Y., Kishi, Y., & Ueno, H. (2019) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12294 · Cited by 60
Links between Inflammation and Postoperative Cancer Recurrence
Kinoshita, T., & Goto, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020228 · Cited by 66
“Systemic Immune-Inflammation Index All NSCLC Small cell lung cancer Esophageal cancer Gastric cancer Pancreatic cancer Urological cancer Melanoma Poor OS, RFS, DFS [193] Poor OS [39,193], poor DFS [39] Poor OS [193] Poor OS [38,193] Poor OS [193,194], poor DFS [194] Poor OS [193] Poor OS [193] Poor OS [193]”
BackgroundJiang, W., Chen, Y., Huang, J., Xi, D., Chen, J., Shao, Y., Xu, G., Ying, W., Wei, J., Chen, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19796 · Cited by 63
“A novel systemic inflammation score-SII, as a prognostic factor for poor survival, was considered to be superior to NLR and PLR in hepatocellular carcinoma [11–13], small cell lung cancer [17], esophageal cancer [14] and gastric cancer [16].”
BackgroundSelf-citationDadouli, K., Janho, M. B., Hatziefthimiou, A., Voulgaridi, I., Piaha, K., Anagnostopoulos, L., Ntellas, P., Mouchtouri, V. A., Bonotis, K., Christodoulou, N., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12081034 · Cited by 57
Could Systemic Inflammatory Index Predict Diabetic Kidney Injury in Type 2 Diabetes Mellitus?
Duman, T. T., Balci, B., & Ozkul, F. N. (2023) · Diagnostics · doi:10.3390/diagnostics13122063 · Cited by 63
Zhang, C., Li, M., Liu, L., Deng, L., Yulei, X., Zhong, Y., Liao, B., Yu, L., & Feng, J. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03849-4 · Cited by 60
“Further studies indicate that, in predicting cardio-vascular disease outcomes, SII may have better prognostic value compared to NLR and PLR [17].”
BackgroundLiu, H., Zhi, J., Zhang, C., Huang, S., Ma, Y., Luo, D., & Shi, L. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.104 · Cited by 56
Tomita, M., Ayabe, T., Maeda, R., & Nakamura, K. (2018) · In Vivo · doi:10.21873/invivo.11291 · Cited by 57
Li, H., Wu, X., Bai, Y., Wei, W., Li, G., Fu, M., Jie, J., Wang, C., Guan, X., Feng, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-91324-x · Cited by 59
Akboğa, M. K., İnanç, İ. H., Şabanoğlu, C., Akdi, A., Yakut, İ., Yüksekkaya, B., Nurkoç, S. G., & Yalçin, R. (2022) · Angiology · doi:10.1177/00033197221125779 · Cited by 52
Matsubara, S., Mabuchi, S., Takeda, Y., Kawahara, N., & Kobayashi, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248871 · Cited by 58
Kang, J., Ning, M. S., Feng, H., Li, H., Bahig, H., Brooks, E. D., Welsh, J. W., Ye, R., Miao, H., & Chang, J. Y. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.09.037 · Cited by 51
“SII which incorporates three hematological items was also superior to NLR and PLR as a survival predictor, consistent with a prior study of esophageal cancer[32].”
ResultZhang, Z., & Chen, Z. (2021) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2021.12.011 · Cited by 46
Wang, J., Liu, Y., Mi, X., Shao, M., & Liu, L. (2020) · Annals of Palliative Medicine · doi:10.21037/apm.2020.04.31 · Cited by 46
Šagud, M., Madžarac, Z., Nedic Erjavec, G., Šimunović Filipčić, I., Mikulić, F. L., Rogić, D., Bradaš, Z., Bajs Janović, M., & Pivac, N. (2023) · Biomolecules · doi:10.3390/biom13020297 · Cited by 39
“It has been recognized as a superior marker that reflects the balance between host inflammatory and immune response status better than PLR, NLR and MLR [11].”
BackgroundSystemic immune-inflammation index: A new marker in differentiation of different thyroid diseases
Vural, S., Muhtaroğlu, A., & Güngör, M. (2023) · Medicine · doi:10.1097/md.0000000000034596 · Cited by 49
“[11,29] Geng et al[30] reported in their study that SII was a more objective marker of host inflammatory and immune response status compared to other systemic inflammation index markers such as platelet-to-lymphocyte ratio and NLR.”
BackgroundYatabe, S., Eto, K., Haruki, K., Shiba, H., Kosuge, M., Ohkuma, M., Ito, D., Takeda, Y., Sugano, H., Sasaki, S., et al. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03615-w · Cited by 48
Jiang, H., Li, D., Xu, T., Chen, Z., Shan, Y., Zhao, L., Fu, G., Luan, Y., Xia, S., & Zhang, W. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.841601 · Cited by 50
Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
Liu, J., Shi, Z., Bai, Y., Liu, L., & Cheng, K. (2019) · Cancer Management and Research · doi:10.2147/cmar.s197623 · Cited by 50
Guo, D. L., Zhang, J., Wang, J., Liu, J., Zhu, H., Fu, L., Li, M., Kong, L., Yue, J., & Yu, J. (2018) · Future Oncology · doi:10.2217/fon-2018-0285 · Cited by 50
Acute Impact of Recovery on the Restoration of Cellular Immunological Homeostasis
Wahl, P., Mathes, S., Bloch, W., & Zimmer, P. (2019) · International Journal of Sports Medicine · doi:10.1055/a-1015-0453 · Cited by 46
Tan, Y., Hu, B., Li, Q., & Cao, W. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03662-z · Cited by 43
Lv, Y., Zhang, S., Liu, Z., Tian, Y., Liang, N., & Zhang, J. (2019) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2019.03.017 · Cited by 39
Yılmaz, B., Somay, E., Selek, U., & Topkan, E. (2021) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s334556 · Cited by 40
Huang, Z., Zheng, Q., Yu, Y., Zheng, H., Wu, Y., Wang, Z., Liu, L., Zhang, M., Liu, T., Li, H., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07546-0 · Cited by 44
Şaylık, F., & Akbulut, T. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210412 · Cited by 42
“HDL colesterol, mg/dL 43(36,3-48,5) 40,4(31,5-51,8) 0,057 Triglicerídeos, mg/dL 137,2(98,6-177,7) 129,8(87,9-204,1) 0,858 Glicose, mg/dL 116(29,5) 114,5(37,6) 0,534 Angiografia Tempo entre dor e dilatação (balão), h 4,3(2,8-5,5) 4,4(2,5-6,5) 0,152”
InfluentialLu, Y., Liu, Q., Yan, H., Gao, S., & Liu, T. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03555-x · Cited by 42
Li, X., Zhang, S., Lü, J., Li, C., & Li, N. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.922595 · Cited by 40
Wang, D., Guo, D. L., Shi, F., Zhu, Y. J., Li, A., Kong, L., Teng, F., & Yu, J. (2019) · Future Oncology · doi:10.2217/fon-2019-0288 · Cited by 41
Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis
Zhao, Q., Zhang, X.-P., Zhang, H., & Duan, G. (2017) · Oncotarget · doi:10.18632/oncotarget.22557 · Cited by 34
“Therefore, 16 studies (17 cohorts) with a total of 6699 patients published between 2011 and 2017 were finally enrolled in our meta-analysis [13-16, 19-30].”
BackgroundSato, B., Kanda, M., Tanaka, C., Kobayashi, D., Iwata, N., Hattori, N., Suenaga, M., Hayashi, M., Yamada, S., Murotani, K., et al. (2018) · World Journal of Surgery · doi:10.1007/s00268-018-4597-7 · Cited by 33
“2 Comparison of survival according to SIS and its constituents. a Disease-specific survival curves of patients with SIS 0, 1, and 2. b Disease-free survival was associated with LMR, preoperative serum albumin levels, and SIS.”
BackgroundInfluentialJomrich, G., Hollenstein, M., John, M., Baierl, A., Paireder, M., Kristo, I., Ilhan‐Mutlu, A., Asari, R., Preusser, M., & SCHOPPMANN, S. F. (2018) · Oncotarget · doi:10.18632/oncotarget.24087 · Cited by 33
Liu, X., Li, X., Chen, Y., Liu, X., Liu, Y., Wei, H., & Li, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1331610 · Cited by 34
Ishibashi, Y., Tsujimoto, H., Sugasawa, H., Kouzu, K., Itazaki, Y., Sugihara, T., Harada, M., Ito, N., Kishi, Y., & Ueno, H. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103427 · Cited by 30
Dolu, A. K., Karayiğit, O., Özkan, C., Çelik, M. C., & Kalçık, M. (2022) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2022.2035082 · Cited by 33
“Many studies have compared the prognostic and predictive effects of SII with NLR and PLR, and SII has been found superior to these other two markers [16,35,36].”
Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
Xu, X., & Jing, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.900305 · Cited by 31
Yang, Y., Xu, H., Zhou, L., Deng, T., Ning, T., Liu, R., Zhang, L., Wang, X., Ge, S., Li, H., et al. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.01.013 · Cited by 29
Systemic immune-inflammation index predicts the outcome after aneurysmal subarachnoid hemorrhage
Luo, F., Li, Y., Zhao, Y., Sun, M., He, Q., Wen, R., & Xie, Z. (2021) · Neurosurgical Review · doi:10.1007/s10143-021-01681-4 · Cited by 31
Liang, R., Chen, N., Mao, L., Wang, X., Mao, Q., & Liu, Y. (2017) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2017.11.011 · Cited by 30
Tzikos, G., Alexiou, I., Tsagkaropoulos, S., Menni, A.-E., Chatziantoniou, G., Doutsini, S., Papavramidis, T., Grosomanidis, V., Stavrou, G., & Kotzampassi, K. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030473 · Cited by 28
Soysal, C., Sarı, H., Işıkalan, M. M., Özkaya, E. B., Ulaş, Ö., Taşçı, Y., & Keskın, N. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15655 · Cited by 32
Anpalakhan, S., Signori, A., Cortellini, A., Verzoni, E., Giusti, R., Aprile, G., Ermacora, P., Catino, A., Pipitone, S., Napoli, M. D., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107970 · Cited by 31
Association between systemic immune-inflammation index and insulin resistance and mortality
Deng, X., Liu, D., Li, M., He, J., & Fu, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-51878-y · Cited by 30
High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
Ito, M., Yajima, S., Suzuki, T., Oshima, Y., Nanami, T., Sumazaki, M., Shiratori, F., Funahashi, K., Tochigi, N., & Shimada, H. (2019) · Cancer Medicine · doi:10.1002/cam4.2789 · Cited by 27
Prognostic value of systemic ımmune ınflammation ındex in patients with laryngeal cancer
Akkaş, E. A., & Yücel, B. (2021) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-021-06798-2 · Cited by 27
“It also acts as a marker that reflects the balance between the inflammatory and immune response statuses of patients [35].”
BackgroundBrewczyński, A., Jabłońska, B., Mazurek, A. M., Mrochem‐Kwarciak, J., Mrowiec, S., Śnietura, M., Kentnowski, M., Kołosza, Z., Składowski, K., & Rutkowski, T. W. (2021) · Cancers · doi:10.3390/cancers13133256 · Cited by 26
Wan, X., Ji, Y., Wang, R., Yang, H., Cao, X., & Lu, S. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02215-9 · Cited by 27
“Recent studies have highlighted the systemic immune-inflammation index (SII) as a reliable indicator of immune response and inflammation in the body [15, 16].”
BackgroundPrognostic role of neutrophil–lymphocyte ratio in esophageal cancer
Zhang, X., Jiang, Y., Wang, Y., Wang, Z., Zhao, L., Xue, X., Sang, S., & Zhang, L. (2018) · Medicine · doi:10.1097/md.0000000000013585 · Cited by 26
Kanda, M., Koike, M., Tanaka, C., Kobayashi, D., Hattori, N., Hayashi, M., Yamada, S., Omae, K., Fujiwara, M., & Kodera, Y. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07914-7 · Cited by 25
“Therefore, a low serum albumin concentration is associated with ongoing systemic inflammation, which promotes cancer progression, culminating in poor survival.(8,23) Moreover, ALB is usually regarded as a good index for malnutrition and cachexia in patients with cancer.”
BackgroundHung, S.-P., Chen, P., Ho, T., Chang, K., Chou, W., Lee, C., Wu, Y., Chen, P., Lin, C., Chou, Y., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3650 · Cited by 27
Deng, J., Zhang, P., Sun, Y., Peng, P., & Huang, Y. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.02.58 · Cited by 28
The relationship between calcific severe aortic stenosis and systemic immune‐inflammation index
Erdoğan, M., Öztürk, S., Kardeşler, B., YİĞİTBAŞI, M. M., Kasapkara, H. A., Baştuğ, S., Erdöl, M. A., Bayram, N., Akçay, M., & Durmaz, T. (2021) · Echocardiography · doi:10.1111/echo.15044 · Cited by 29
“Peak aortic gradient, mmHg, mean (SD) – 91 (23) 60 (11) <.”
Predictive Medicine for Salivary Gland Tumours Identification Through Deep Learning
Prezioso, E., Izzo, S., Giampaolo, F., Piccialli, F., Orabona, G. D., Cuocolo, R., Abbate, V., Ugga, L., & Califano, L. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2021.3120178 · Cited by 25
Yang, C., Hu, B.-W., Tang, F. R., Zhang, Q. H., Quan, W., Wang, J., Wang, X., Li, Y., & Li, Z. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247514 · Cited by 25
“The SII, calculated using the absolute measures of platelets, neutrophils, and lymphocytes obtained from routine complete blood counts [19], has been suggested as a biomarker superior to both the NLR and PLR in prognosis prediction [33].”
MethodWang, P., Yue, W., Li, W., Luo, Y., Li, Z., Shao, Y., & He, Z. (2019) · Cancer Management and Research · doi:10.2147/cmar.s185890 · Cited by 28
Self-citationTian, H., Xu, B., Wang, L.-N., Wang, Z., Shi, H.-C., Zhong, C., Zhu, X.-D., Shen, Y., Zhou, J., Fan, J., et al. (2025) · Biomarker Research · doi:10.1186/s40364-024-00722-6 · Cited by 24
Gao, G.-D., Sun, B., Wang, X.-B., & Wang, S.-M. (2017) · The International Journal of Biological Markers · doi:10.5301/ijbm.5000294 · Cited by 23
Peng, J., Wang, H., Zhang, L., & Lin, Z. (2021) · PubMed Central · doi:10.11817/j.issn.1672-7347.2021.190722 · Cited by 23
Systemic immune inflammation index in differentiated thyroid cancers
Kars, A., Şahin, A., Kılıç, K., Sakat, M. S., & Bilen, A. (2022) · Acta Otorhinolaryngologica Italica · doi:10.14639/0392-100x-n1665 · Cited by 25
“Geng et al. 16 described SII as an objective marker superior to indices such as PLR, and NLR. High N and P levels and low L levels produce an increase in SII, resulting in an increased inflammatory response and decreased immune response in cancer patients.”
BackgroundQi, W., Zhou, Y., Liu, Z., Wang, J., Lv, G., Zhong, M., Wang, W., Li, R., Chen, S., Shi, B., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1052943 · Cited by 23
Zhong, Q., Zhou, W., Lin, J., Sun, W. C., Qin, Y., Li, X., & Xu, H. (2023) · Toxics · doi:10.3390/toxics11080659 · Cited by 22
“High SII values are frequently accompanied by lymphopenia, neutropenia, or thrombocytosis [59].”
BackgroundSelf-citationShao, M., Li, W., Wang, S., & Liu, Z. (2020) · Journal of Cancer · doi:10.7150/jca.30699 · Cited by 24
“It has been reported that immune response and immune escape might play a critical role in ESCC progression and therapy [21, 22].”
BackgroundTopkan, E., Beşen, A. A., Özdemir, Y., Küçük, A., Mertsoylu, H., Pehlivan, B., & Selek, U. (2020) · Mediators of Inflammation · doi:10.1155/2020/4392189 · Cited by 23
Han, D., Zhang, J., Zhao, J., Lei, T., Chen, X., Zhang, T., Wei, H., Guan, Y., Wang, J., Zhang, W., et al. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-4053 · Cited by 22
Ding, T.-Y., Liu, C.-T., Huang, B.-L., Chu, L., Wei, L., Lin, Y., Luo, Y., Zhang, B., Hong, C., Xu, Y., et al. (2021) · Cancer Management and Research · doi:10.2147/cmar.s329687 · Cited by 23
Zeng, P., Jiang, C. S., Liu, A., Yang, X., Lin, F., & Cheng, L. (2024) · BMC Geriatrics · doi:10.1186/s12877-023-04635-1 · Cited by 23
“Moreover, some studies have reported that SII may offer a more reliable prediction of disease progression and outcomes in certain inflammation-related diseases, such as cardiovascular diseases [19, 20], cancer [21–23], and metabolic disorders [24, 25].”
BackgroundAqua cycling for immunological recovery after intensive, eccentric exercise
Joisten, N., Walzik, D., Schenk, A., Bloch, W., Zimmer, P., & Wahl, P. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04127-4 · Cited by 21
Wang, H., Luo, M., Yang, Y., Li, S., Song, L., Xu, R., Zhu, J., & Song, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39015 · Cited by 25
“Recently, a new comprehensive systemic immune-inflammatory index (SII) based on neutrophil, platelet and lymphocyte counts was developed to adequately reflect the balance of host immune and inflammatory status [26,27].”
BackgroundPrognostic value of the C-reactive protein to albumin ratio in patients with stroke: a meta-analysis
Yang, J., Chen, Y., Wan, J., Li, F., Yang, X., Shen, B., Li, N., Didi, J., Zhou, L., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-07327-5 · Cited by 20
Çelik, M. C., Karayiğit, O., Özkan, C., Dolu, A. K., & Kalçık, M. (2022) · Angiology · doi:10.1177/00033197221115562 · Cited by 24
“In addition to platelet count, higher platelet reactivity may be associated with the presence of microvascular obstruction diagnosed in STEMI patients undergoing pPCI.31 In line with current studies, inflammatory cells (such as WBC or other hematological parameters) can be used to predict prognosis in patients with ac…”
BackgroundPretreatment inflammatory indexes as prognostic predictors for survival in osteosarcoma patients.
Yang, S., Wu, C., Wang, L., Shan, D., & Chen, B. (2020) · PubMed · Cited by 23
Self-citationNonlinear association of the systemic immune-inflammatory index with mortality in diabetic patients
Meng, C., & Liu, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1334811 · Cited by 21
Metadata
- Authors
- Geng, Y., Shao, Y., Zhu, D., Zheng, X., Zhou, Q., Zhou, W., Ni, X., Wu, C., & Jiang, J.
- Affiliations
- Soochow University (CN)
- Corresponding author
- Wu, Changping
- Jiang, Jingting
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-12-21
- Volume
- 6
- Issue
- 1
- Pages
- 39482-39482
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5175190
- OpenAlex
- W2563208071
- Cited by
- 233
- References
- 29
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 36 · 2023: 33 · 2022: 24 · 2021: 41 · 2020: 23 · 2019: 23 · 2018: 16 · 2017: 7
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31570877, 81301960)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- systemic immune-inflammation index, esophageal squamous cell carcinoma, prognostic factors, overall survival, radical esophagectomy, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic inflammation, lymphocyte count, platelet count, neutrophil count
- MeSH terms
- Esophageal Squamous Cell Carcinoma, Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell, Esophageal Neoplasms, Female, Humans, Immunity, Inflammation, Male, Middle Aged, Prognosis, Regression Analysis, Retrospective Studies, Risk Factors, ROC Curve, Multivariate Analysis, Proportional Hazards Models, Esophagectomy, Kaplan-Meier Estimate, Propensity Score
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.